Global health governance must depend less on the FDA

What Happened

The FDA has long influenced drug and vaccine approvals worldwide, particularly in low- and middle-income countries. Recent leadership turnover, budget pressures, and regulatory changes at the agency create uncertainty in global health governance. India and other nations are strengthening their own regulatory capacities and exploring regional cooperation to reduce reliance on FDA decisions. Experts recommend balancing established regulators with developing stronger national and regional regulatory systems.

Key Entities

AI Tools